Related Experiment Video
Updated: Jul 31, 2026

Murine Prostate Micro-dissection and Surgical Castration
Published on: May 11, 2016
Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse
A Di Cristofano1, M De Acetis, A Koff
1Department of Human Genetics, Memorial Sloan-Kettering Cancer Center, Sloan-Kettering Institute, New York, New York, USA.
Abstract:
The genetic bases underlying prostate tumorigenesis are poorly understood. Inactivation of the tumor-suppressor gene PTEN and lack of p27(KIP1) expression have been detected in most advanced prostate cancers. But mice deficient for Cdkn1b (encoding p27(Kip1)) do not develop prostate cancer. PTEN activity leads to the induction of p27(KIP1) expression, which in turn can negatively regulate the transition through the cell cycle. Thus, the inactivation of p27(KIP1) may be epistatic to PTEN in the control of the cell cycle. Here we show that the concomitant inactivation of one Pten allele and one or both Cdkn1b alleles accelerates spontaneous neoplastic transformation and incidence of tumors of various histological origins. Cell proliferation, but not cell survival, is increased in Pten(+/-)/Cdkn1b(-/-) mice. Moreover, Pten(+/-)/Cdkn1b(-/-) mice develop prostate carcinoma at complete penetrance within three months from birth. These cancers recapitulate the natural history and pathological features of human prostate cancer. Our findings reveal the crucial relevance of the combined tumor-suppressive activity of Pten and p27(Kip1) through the control of cell-cycle progression.
Insights
The tumor suppressor genes PTEN and p27(KIP1) are crucial for preventing prostate cancer. Inactivating both genes accelerates tumor development, highlighting their combined role in cell-cycle control.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Prostate cancer development is linked to PTEN tumor suppressor gene inactivation and reduced p27(KIP1) expression.
- While PTEN inactivation is common in advanced prostate cancers, mice lacking p27(KIP1) do not develop the disease.
- PTEN influences p27(KIP1) expression, which regulates cell cycle transition, suggesting p27(KIP1) inactivation might be downstream of PTEN.
Purpose of the Study:
- To investigate the combined role of PTEN and p27(KIP1) in prostate tumorigenesis.
- To determine if simultaneous genetic alterations in Pten and Cdkn1b accelerate cancer development.
- To elucidate the impact of combined Pten and Cdkn1b inactivation on cell proliferation and survival.
Main Methods:
- Utilized genetically modified mouse models with combined Pten and Cdkn1b allele inactivation (Pten(+/-)/Cdkn1b(-/-)).
- Monitored tumor incidence, latency, and histological characteristics.
- Assessed cell proliferation and survival rates in the experimental mouse cohorts.
Main Results:
- Concomitant inactivation of one Pten allele and one or both Cdkn1b alleles significantly accelerated spontaneous tumor formation across various tissues.
- Pten(+/-)/Cdkn1b(-/-) mice exhibited increased cell proliferation but not cell survival.
- These mice developed prostate carcinoma with complete penetrance within three months, mirroring human prostate cancer pathology.
Conclusions:
- The combined tumor-suppressive functions of Pten and p27(Kip1) are critical for controlling cell-cycle progression and preventing prostate cancer.
- Simultaneous loss of Pten and p27(Kip1) function cooperatively drives neoplastic transformation and prostate carcinoma development.
- This study underscores the importance of the PTEN/p27(KIP1) pathway in prostate tumorigenesis and provides a relevant preclinical model.
Related Concept Videos
Inhibition of Cdk Activity
Abnormal Proliferation
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

